The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...

Scientists with the Fralin Biomedical Research Institute at VTC have created an engineered model of the supportive tissue found within a lymph node ...

Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized ...

Renal failure in multiple myeloma typically occurs when the kidneys fail to filter waste products from the blood, leading to ...

KNOWN for its strong, pine-like flavour and its use in various dishes, rosemary has a lot more going for it than its scent ...

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based ...

Weizmann scientists uncover why our immune system lets us eat without harm, how it tolerates food—and why it sometimes fails.

The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, ...

Like a bunny boiler who refuses to die in a horror movie, the Covid jabs are back. Headlines trumpet the familiar narrative: ...

A newly identified rare cell subset that drives immune tolerance in dietary and gut microbiota may offer a new therapeutic ...

ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Kevin Zarrabi discussing the molecular characterization of STEAP1 and STEAP2 in advanced prostate cancer. STEAP 1 and 2 ...

Breakthrough nanovaccine uses tumor cell membranes and immune-boosting polymers to enhance personalized cancer immunotherapy, ...